Vir Biotechnology Inc. logo

Vir Biotechnology Inc.

VIR | NASDAQ
Chart Builder DCF Calculator
$10.88
+$0.28 (+2.64%)
At close: Sep 21, 2026, 4:00 PM ET
$11.31
+$0.43 (+3.95%)
After-hours: Sep 21, 2026, 7:30 PM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-437.99M -521.96M -615.06M 515.84M 528.58M -298.67M
Depreciation & Amortization
21.15M 14.56M 19.45M 6.78M 5.81M 5.44M
Stock-Based Compensation
49.07M 78.46M n/a 102.08M 83.78M 27.6M
Other Working Capital
-27.44M -76.51M -304.76M -105.47M 92.04M 30.31M
Other Non-Cash Items
-1.57M 69.55M 122.48M 388.37M -52.56M 45.21M
Deferred Income Tax
n/a -2.95M -1.06M -15.19M 15.19M -52K
Change in Working Capital
-22.45M -84.01M -304.59M 665.37M -628.39M 29.52M
Operating Cash Flow
-391.78M -446.35M -778.79M 1.66B -47.59M -190.94M
Capital Expenditures
-4.83M -7.3M -21.57M -68.01M -21.82M -6.55M
Cash Acquisitions
253K 3.37M 100K n/a 140.81M n/a
Purchase of Investments
-886.33M -1.24B -2.02B -1.48B -420.24M -403.84M
Sales Maturities Of Investments
1.2B 1.74B 2.2B 351.51M 301.24M 400.35M
Other Investing Acitivies
n/a n/a n/a n/a -140.81M 180K
Investing Cash Flow
310.37M 499.37M 164.73M -1.19B -140.81M -9.86M
Debt Repayment
-361K -165K -287K -260K -259K -250K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a -100K 6.56M 15.38M -189K
Financial Cash Flow
3.79M 4.39M 7.38M 34.76M 100.33M 529.47M
Net Cash Flow
-77.63M 57.4M -606.47M 504.55M -88.07M 328.67M
Free Cash Flow
-396.61M -453.65M -800.36M 1.6B -69.41M -197.49M
Adj. Free Cash Flow
-445.69M -532.11M -800.36M 1.49B -153.19M -225.09M
Maintenance CapEx
-4.83M -7.3M -21.57M n/a n/a n/a
Growth CapEx
n/a n/a n/a -68.01M -21.82M -6.55M
Owner Earnings
-396.61M -453.65M -800.36M 1.66B -47.59M -190.94M

© 2026 bestshares.com. All rights reserved.